LOOKING FORWARD TO POTENTIAL BENEFITS
As you begin your Rituxan® (rituximab) treatment, you may be wondering when you may see results and how long they might last. In studies, people who were treated with Rituxan also received methotrexate and glucocorticoids, a type of steroid. At the time of their first checkup—8 weeks after their first infusion—many of those people had seen an improvement in their symptoms. And up to 6 months later, many were still experiencing improvement. Individual results may vary. See below to read more about the results of that trial.
UP TO 6 MONTHS OF SYMPTOM IMPROVEMENT
Rituxan has been shown to provide up to 6 months of symptom improvement from rheumatoid arthritis (RA) in 1 course of treatment (2 infusions, given 2 weeks apart). In fact, a study showed that at 6 months, 51% of the people taking Rituxan (plus methotrexate) experienced RA symptom improvement (called an ACR20 response), as opposed to 18% of people taking methotrexate alone.
A study also showed that, of the people who saw improvement from their first course of Rituxan (plus methotrexate) and then went on to receive a second course, 54% saw an additional 6 months of improvement (as opposed to 45% of people who received methotrexate alone).
SERIOUS SIDE EFFECT INFORMATION
Rituxan can cause serious side effects that can lead to death, including:
- Hepatitis B Virus (HBV) Reactivation: Before Rituxan treatment, your doctor will do blood tests to check for HBV infection. If you have had hepatitis B or are a carrier of hepatitis B virus, receiving Rituxan could cause the virus to become an active infection again. Hepatitis B reactivation may cause serious liver problems, including liver failure, and death. You should not receive Rituxan if you have active hepatitis B liver disease. Your doctor will monitor you for hepatitis B infection during and for several months after you stop receiving Rituxan
For more information, please visit the Important Side Effect Information page.